Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Mitchell

Concepts (452)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonectomy
43
2026
167
6.970
 Why?
Mycobacterium Infections, Nontuberculous
12
2026
368
3.630
 Why?
Anesthesiology
15
2026
178
3.480
 Why?
Thoracic Surgery
17
2026
144
3.160
 Why?
Esophageal Neoplasms
19
2025
346
2.580
 Why?
Lung Neoplasms
41
2025
2660
2.410
 Why?
Internship and Residency
18
2026
1262
2.260
 Why?
Thoracic Surgical Procedures
14
2025
95
2.190
 Why?
Clinical Competence
19
2025
1237
2.140
 Why?
Lung Diseases
10
2026
781
2.110
 Why?
Thoracic Surgery, Video-Assisted
12
2026
48
1.700
 Why?
Carcinoma, Non-Small-Cell Lung
18
2025
1186
1.550
 Why?
Anesthesiologists
3
2025
68
1.480
 Why?
Nontuberculous Mycobacteria
6
2024
210
1.450
 Why?
Educational Measurement
6
2025
325
1.450
 Why?
Echocardiography, Transesophageal
7
2022
132
1.440
 Why?
Esophagectomy
14
2024
135
1.390
 Why?
Education, Medical, Graduate
8
2025
562
1.330
 Why?
Postoperative Complications
29
2025
2950
1.280
 Why?
Surgeons
8
2026
341
1.130
 Why?
Anesthesia
5
2023
258
0.980
 Why?
Bronchiectasis
3
2012
112
0.960
 Why?
Perioperative Care
5
2025
231
0.910
 Why?
Tuberculosis, Pulmonary
3
2018
131
0.900
 Why?
Adenocarcinoma
8
2024
923
0.880
 Why?
Lung Transplantation
7
2019
329
0.850
 Why?
Empyema, Pleural
2
2015
13
0.850
 Why?
Societies, Medical
11
2025
890
0.820
 Why?
Humans
151
2026
144667
0.820
 Why?
Robotic Surgical Procedures
6
2024
183
0.820
 Why?
Neoplasm Staging
16
2025
1465
0.790
 Why?
Curriculum
7
2023
1063
0.720
 Why?
Central Venous Catheters
1
2022
52
0.680
 Why?
Catheterization, Central Venous
1
2022
124
0.620
 Why?
Physicians, Women
3
2026
88
0.610
 Why?
Minimally Invasive Surgical Procedures
6
2024
189
0.600
 Why?
Ultrasonography, Interventional
2
2018
161
0.600
 Why?
Teaching
3
2021
237
0.580
 Why?
Ischemic Preconditioning
3
2024
47
0.580
 Why?
Pleura
2
2024
28
0.510
 Why?
Thoracic Wall
1
2017
21
0.510
 Why?
Practice Guidelines as Topic
6
2017
1569
0.510
 Why?
Soft Tissue Infections
1
2017
39
0.500
 Why?
Abscess
1
2017
76
0.490
 Why?
Thoracoscopy
5
2020
60
0.490
 Why?
Biomedical Research
4
2026
712
0.490
 Why?
Bronchial Fistula
2
2015
4
0.480
 Why?
Databases, Factual
14
2025
1494
0.480
 Why?
Respiratory Tract Fistula
2
2015
7
0.470
 Why?
Pleural Diseases
2
2015
23
0.470
 Why?
Female
74
2026
78304
0.470
 Why?
Anastomosis, Surgical
3
2024
161
0.460
 Why?
Tomography, X-Ray Computed
10
2018
2754
0.460
 Why?
Male
69
2026
72431
0.460
 Why?
Thoracotomy
6
2019
80
0.460
 Why?
Laparoscopy
4
2024
477
0.450
 Why?
Pneumonia, Bacterial
2
2013
113
0.450
 Why?
Middle Aged
55
2026
35971
0.440
 Why?
Osteomyelitis
1
2017
141
0.440
 Why?
Aged
44
2025
25955
0.430
 Why?
Time-to-Treatment
3
2025
242
0.420
 Why?
Computer Simulation
5
2021
1021
0.420
 Why?
Computer-Assisted Instruction
1
2014
71
0.410
 Why?
Hypothermia
2
2025
52
0.410
 Why?
Retrospective Studies
30
2025
17149
0.400
 Why?
Chest Tubes
1
2013
34
0.390
 Why?
United States
27
2026
16018
0.390
 Why?
Equipment Contamination
1
2013
71
0.390
 Why?
Length of Stay
8
2024
1339
0.380
 Why?
Education, Medical
2
2026
273
0.380
 Why?
Tracheobronchomalacia
1
2012
15
0.370
 Why?
Internet
2
2014
698
0.370
 Why?
Treatment Outcome
20
2025
11735
0.370
 Why?
Tuberculosis, Multidrug-Resistant
1
2012
50
0.350
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1961
0.350
 Why?
Anti-Bacterial Agents
6
2024
1928
0.340
 Why?
Sputum
1
2013
308
0.340
 Why?
Pneumoperitoneum
1
2010
12
0.320
 Why?
Coronary Artery Bypass
2
2015
267
0.320
 Why?
Conversion to Open Surgery
2
2020
22
0.320
 Why?
Trachea
3
2022
258
0.310
 Why?
Accreditation
3
2025
101
0.310
 Why?
Prospective Studies
14
2024
7994
0.310
 Why?
Combined Modality Therapy
6
2022
1268
0.300
 Why?
Early Detection of Cancer
1
2015
472
0.300
 Why?
Faculty, Medical
2
2026
301
0.300
 Why?
Mass Screening
2
2015
1348
0.290
 Why?
Simulation Training
2
2021
135
0.280
 Why?
Specialties, Surgical
2
2023
82
0.270
 Why?
Heart Diseases
2
2022
341
0.270
 Why?
Cost of Illness
1
2010
322
0.270
 Why?
Small Cell Lung Carcinoma
2
2024
121
0.260
 Why?
Mycobacterium avium-intracellulare Infection
1
2008
63
0.260
 Why?
Workflow
2
2021
182
0.260
 Why?
Induction Chemotherapy
2
2024
87
0.250
 Why?
Pleural Neoplasms
2
2024
29
0.250
 Why?
Airway Obstruction
2
2022
153
0.240
 Why?
Diaphragm
2
2023
48
0.240
 Why?
Benchmarking
3
2023
189
0.240
 Why?
Prognosis
10
2025
4312
0.230
 Why?
Patient Satisfaction
1
2010
707
0.230
 Why?
Esophageal Diseases
1
2006
30
0.230
 Why?
Professionalism
1
2026
26
0.230
 Why?
Postoperative Care
3
2012
286
0.230
 Why?
Fever
1
2007
313
0.230
 Why?
Chemoradiotherapy
2
2024
239
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.230
 Why?
Anesthetics
2
2022
99
0.220
 Why?
Thoracic Neoplasms
1
2005
39
0.220
 Why?
Adult
30
2026
40489
0.220
 Why?
Organizational Culture
1
2026
160
0.210
 Why?
Genes, Plant
1
2024
46
0.210
 Why?
Vulnerable Populations
1
2025
175
0.210
 Why?
Certification
1
2025
118
0.200
 Why?
Magnoliopsida
1
2024
34
0.200
 Why?
Patient Readmission
3
2019
765
0.200
 Why?
Esophagogastric Junction
3
2024
56
0.200
 Why?
Workplace
1
2026
270
0.200
 Why?
Carcinoma, Bronchogenic
1
2003
20
0.200
 Why?
Preoperative Care
3
2012
379
0.200
 Why?
Respiratory Paralysis
1
2023
4
0.200
 Why?
Esophageal Stenosis
1
2024
60
0.200
 Why?
Interleukin-6
1
2007
770
0.190
 Why?
Mentors
1
2025
214
0.190
 Why?
Research
1
2026
431
0.190
 Why?
Perception
1
2026
376
0.190
 Why?
Plasmacytoma
1
2022
19
0.190
 Why?
Tracheal Neoplasms
1
2022
12
0.190
 Why?
Guideline Adherence
2
2024
586
0.190
 Why?
Neoplasms, Second Primary
1
2024
101
0.190
 Why?
Aged, 80 and over
13
2024
8284
0.190
 Why?
Bronchi
2
2007
263
0.180
 Why?
Cardiovascular Diseases
4
2019
2172
0.180
 Why?
Survival Rate
6
2025
2089
0.180
 Why?
Neoplasm Recurrence, Local
4
2024
1145
0.180
 Why?
Ascites
1
2002
48
0.180
 Why?
Propensity Score
3
2019
373
0.180
 Why?
Patient Selection
5
2015
727
0.180
 Why?
Endometriosis
1
2002
57
0.180
 Why?
Pleural Effusion
1
2002
59
0.170
 Why?
Pandemics
4
2025
1700
0.170
 Why?
Periodicals as Topic
1
2024
206
0.170
 Why?
Leukemia
1
2024
245
0.170
 Why?
Neoadjuvant Therapy
5
2024
464
0.170
 Why?
Credentialing
1
2021
21
0.170
 Why?
Social Determinants of Health
1
2025
305
0.170
 Why?
Infectious Disease Transmission, Patient-to-Professional
1
2021
20
0.170
 Why?
Interdisciplinary Research
1
2021
26
0.170
 Why?
Leadership
1
2025
400
0.160
 Why?
Bronchoscopy
4
2012
227
0.160
 Why?
Technology
1
2021
95
0.160
 Why?
Sarcoma
1
2003
203
0.160
 Why?
Disease-Free Survival
4
2024
768
0.160
 Why?
Cardiovascular Abnormalities
1
2020
15
0.160
 Why?
Subclavian Artery
1
2020
28
0.160
 Why?
Cohort Studies
6
2025
5957
0.160
 Why?
Carotid Artery, Common
1
2020
31
0.160
 Why?
Education, Distance
1
2021
58
0.160
 Why?
Robotics
1
2021
89
0.150
 Why?
Developing Countries
1
2022
317
0.150
 Why?
Evolution, Molecular
1
2024
518
0.150
 Why?
Phylogeny
1
2024
1024
0.150
 Why?
Anastomotic Leak
3
2024
45
0.150
 Why?
Attitude of Health Personnel
2
2026
1180
0.150
 Why?
Educational Status
1
2021
463
0.150
 Why?
Stomach
3
2024
109
0.140
 Why?
Burnout, Professional
1
2026
483
0.140
 Why?
Genomics
1
2024
831
0.140
 Why?
Metastasectomy
1
2018
19
0.140
 Why?
Carcinoma, Squamous Cell
3
2012
643
0.140
 Why?
General Surgery
1
2021
206
0.140
 Why?
Quality of Life
3
2024
3183
0.140
 Why?
Pulmonary Emphysema
2
2015
275
0.140
 Why?
Manikins
1
2018
36
0.140
 Why?
Feasibility Studies
3
2018
1103
0.140
 Why?
Healthcare Disparities
1
2025
736
0.130
 Why?
Anesthesia, Cardiac Procedures
1
2017
27
0.130
 Why?
Forms and Records Control
1
2017
20
0.130
 Why?
Negative-Pressure Wound Therapy
1
2017
29
0.130
 Why?
Pylorus
1
2017
17
0.130
 Why?
Gastric Outlet Obstruction
1
2017
12
0.130
 Why?
Learning
1
2021
448
0.120
 Why?
Consensus
1
2018
475
0.120
 Why?
NADPH Oxidases
1
2017
120
0.120
 Why?
Antigen Presentation
1
2017
206
0.120
 Why?
Clinical Protocols
3
2024
282
0.120
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
152
0.120
 Why?
Pain Management
1
2020
410
0.120
 Why?
Neuromuscular Agents
1
2017
45
0.120
 Why?
Frailty
1
2019
200
0.120
 Why?
CD4-Positive T-Lymphocytes
2
2017
1129
0.120
 Why?
Botulinum Toxins, Type A
1
2017
58
0.120
 Why?
Program Development
1
2017
368
0.110
 Why?
Cause of Death
1
2017
464
0.110
 Why?
Patient-Centered Care
1
2020
545
0.110
 Why?
Documentation
1
2017
198
0.110
 Why?
Kidney Neoplasms
2
2009
412
0.110
 Why?
Extracorporeal Membrane Oxygenation
1
2019
387
0.110
 Why?
Pulmonary Disease, Chronic Obstructive
2
2015
919
0.110
 Why?
Radiotherapy Dosage
1
2015
288
0.110
 Why?
Forecasting
2
2026
391
0.110
 Why?
Chronic Disease
3
2017
1810
0.100
 Why?
Risk Factors
7
2024
10796
0.100
 Why?
Asphyxia
1
2014
23
0.100
 Why?
Risk
2
2015
911
0.100
 Why?
Chemotherapy, Adjuvant
2
2005
427
0.100
 Why?
Follow-Up Studies
4
2025
5414
0.100
 Why?
Dyspnea
2
2023
250
0.100
 Why?
Diabetes Mellitus
1
2022
1076
0.100
 Why?
Suture Techniques
2
2006
137
0.100
 Why?
Intubation, Intratracheal
1
2016
323
0.100
 Why?
Health Expenditures
1
2015
194
0.100
 Why?
Myocardial Infarction
1
2021
1209
0.100
 Why?
Perfusion
1
2014
249
0.100
 Why?
Group II Phospholipases A2
1
2012
10
0.090
 Why?
Carcinoma, Large Cell
1
2012
17
0.090
 Why?
Patient Discharge
1
2019
985
0.090
 Why?
Mutation
3
2022
4081
0.090
 Why?
Extensively Drug-Resistant Tuberculosis
1
2012
6
0.090
 Why?
Consumer Health Information
1
2013
49
0.090
 Why?
Radiography
1
2014
848
0.090
 Why?
Ultrasonography
1
2016
776
0.090
 Why?
Volatile Organic Compounds
1
2012
60
0.090
 Why?
Time Factors
5
2024
7140
0.090
 Why?
Cardiology
1
2015
359
0.090
 Why?
Cost-Benefit Analysis
1
2015
638
0.090
 Why?
B-Lymphocytes
1
2017
875
0.090
 Why?
ErbB Receptors
2
2022
632
0.090
 Why?
ras Proteins
1
2012
151
0.090
 Why?
Tracheal Stenosis
1
2012
39
0.090
 Why?
Smoking
2
2017
1467
0.080
 Why?
Physician's Role
1
2013
221
0.080
 Why?
Logistic Models
4
2019
2114
0.080
 Why?
Risk Assessment
4
2023
3729
0.080
 Why?
Cardiac Surgical Procedures
2
2017
609
0.080
 Why?
Morbidity
3
2023
322
0.080
 Why?
Mycobacterium Infections
1
2011
61
0.080
 Why?
Atrial Flutter
1
2011
47
0.080
 Why?
Antitubercular Agents
1
2012
216
0.080
 Why?
Tissue and Organ Procurement
1
2014
341
0.080
 Why?
Hemoptysis
1
2010
35
0.080
 Why?
Syndrome
1
2011
379
0.080
 Why?
Oxidative Stress
1
2017
1338
0.080
 Why?
Quality Improvement
4
2020
1287
0.080
 Why?
Neoplasm Invasiveness
3
2024
503
0.080
 Why?
Hospital Costs
1
2010
125
0.070
 Why?
Mycobacterium
1
2011
116
0.070
 Why?
DNA-Binding Proteins
1
2017
1484
0.070
 Why?
Carcinoma, Papillary
1
2009
77
0.070
 Why?
Proto-Oncogene Proteins
1
2012
619
0.070
 Why?
Teratoma
1
2010
124
0.070
 Why?
Enzyme Inhibitors
1
2012
820
0.070
 Why?
Patient Reported Outcome Measures
2
2024
496
0.070
 Why?
Kaplan-Meier Estimate
2
2023
967
0.070
 Why?
Transcription Factors
1
2017
1726
0.070
 Why?
Lymph Nodes
2
2023
501
0.070
 Why?
Reoperation
2
2008
624
0.070
 Why?
Carcinoid Tumor
1
2008
21
0.070
 Why?
Intraoperative Care
1
2008
63
0.070
 Why?
Mountaineering
1
2008
36
0.070
 Why?
Multivariate Analysis
3
2019
1537
0.070
 Why?
Stents
1
2012
557
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Thrombectomy
1
2008
78
0.070
 Why?
Qualitative Research
2
2026
1668
0.070
 Why?
Registries
1
2016
2392
0.070
 Why?
Vena Cava, Inferior
1
2008
81
0.070
 Why?
Positron-Emission Tomography
2
2009
343
0.070
 Why?
Neoplasm, Residual
1
2008
139
0.070
 Why?
Respiratory Sounds
1
2008
103
0.060
 Why?
Li-Fraumeni Syndrome
1
2007
15
0.060
 Why?
Heart Failure
1
2021
2324
0.060
 Why?
Nephrectomy
1
2008
158
0.060
 Why?
Surgical Flaps
1
2008
142
0.060
 Why?
Chromosome Aberrations
1
2007
164
0.060
 Why?
Renal Dialysis
1
2011
465
0.060
 Why?
Barrett Esophagus
1
2009
165
0.060
 Why?
Urinary Bladder Neoplasms
1
2009
260
0.060
 Why?
Reproducibility of Results
3
2023
3414
0.060
 Why?
Cross-Sectional Studies
3
2026
5870
0.060
 Why?
Pyrimidines
1
2010
519
0.060
 Why?
Carbonic Anhydrases
1
2006
11
0.060
 Why?
Sulfonamides
1
2010
579
0.060
 Why?
Mediastinoscopy
1
2005
5
0.060
 Why?
Delivery of Health Care
1
2013
944
0.060
 Why?
Sialoglycoproteins
1
2006
157
0.060
 Why?
Hyaluronan Receptors
1
2006
104
0.060
 Why?
Vascular Surgical Procedures
1
2009
343
0.060
 Why?
Fatigue
2
2023
363
0.060
 Why?
Precancerous Conditions
1
2007
166
0.060
 Why?
Carcinoma, Renal Cell
1
2008
234
0.060
 Why?
Decision Making
1
2013
973
0.060
 Why?
Atrial Fibrillation
1
2011
555
0.060
 Why?
Sexism
1
2026
69
0.050
 Why?
Blood Loss, Surgical
1
2005
110
0.050
 Why?
Radiotherapy, Adjuvant
1
2005
223
0.050
 Why?
Hospital Mortality
2
2019
1033
0.050
 Why?
Heart-Lung Transplantation
1
2004
13
0.050
 Why?
Chylothorax
1
2004
20
0.050
 Why?
Antigens, Neoplasm
1
2006
272
0.050
 Why?
Odds Ratio
2
2019
1076
0.050
 Why?
Insulin Infusion Systems
1
2009
477
0.050
 Why?
Apoptosis
1
2012
2397
0.050
 Why?
Diagnosis, Differential
2
2010
1501
0.050
 Why?
Antineoplastic Agents
2
2012
2201
0.050
 Why?
Emergencies
1
2025
175
0.050
 Why?
Career Choice
1
2026
233
0.050
 Why?
Cytogenetic Analysis
1
2003
33
0.050
 Why?
Fossils
1
2024
77
0.050
 Why?
Job Satisfaction
1
2026
235
0.050
 Why?
Contraindications
1
2003
90
0.050
 Why?
Evidence-Based Medicine
2
2017
732
0.050
 Why?
Constriction, Pathologic
1
2024
249
0.050
 Why?
Biomarkers, Tumor
2
2007
1319
0.050
 Why?
Mesoderm
1
2003
146
0.050
 Why?
Airway Management
1
2022
82
0.040
 Why?
Advisory Committees
1
2023
228
0.040
 Why?
Lung
4
2024
4089
0.040
 Why?
Cell Survival
2
2017
1092
0.040
 Why?
Surveys and Questionnaires
2
2026
6041
0.040
 Why?
Sex Factors
1
2007
2104
0.040
 Why?
Learning Curve
1
2021
70
0.040
 Why?
Operating Rooms
1
2022
143
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
230
0.040
 Why?
Data Warehousing
1
2020
5
0.040
 Why?
Oxygen
1
2006
984
0.040
 Why?
Socioeconomic Factors
1
2024
1322
0.040
 Why?
Case-Control Studies
2
2024
3603
0.040
 Why?
Intermediate Care Facilities
1
2019
4
0.040
 Why?
Gene Expression Regulation, Neoplastic
3
2012
1437
0.040
 Why?
Survival Analysis
2
2017
1370
0.040
 Why?
Margins of Excision
1
2019
51
0.040
 Why?
Recurrence
1
2023
1136
0.040
 Why?
Cytokines
1
2007
2045
0.040
 Why?
Psychometrics
1
2023
731
0.040
 Why?
Walk Test
1
2019
80
0.040
 Why?
Imaging, Three-Dimensional
1
2003
581
0.040
 Why?
Nuclear Proteins
1
2024
741
0.040
 Why?
Serum Albumin
1
2019
144
0.040
 Why?
Radiography, Thoracic
2
2010
172
0.030
 Why?
Insulin
1
2009
2502
0.030
 Why?
Sarcopenia
1
2019
91
0.030
 Why?
Skilled Nursing Facilities
1
2019
151
0.030
 Why?
Lymphocyte Count
1
2017
164
0.030
 Why?
NADPH Oxidase 4
1
2017
7
0.030
 Why?
Antigen-Presenting Cells
1
2017
159
0.030
 Why?
Algorithms
1
2005
1844
0.030
 Why?
Regression Analysis
1
2019
998
0.030
 Why?
Glutathione Disulfide
1
2017
32
0.030
 Why?
Continuity of Patient Care
1
2019
293
0.030
 Why?
Gastric Emptying
1
2017
36
0.030
 Why?
Geography
1
2017
203
0.030
 Why?
Incidence
1
2023
2892
0.030
 Why?
Patient Care Team
1
2022
690
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2022
990
0.030
 Why?
Immunophenotyping
1
2017
318
0.030
 Why?
Superoxides
1
2017
199
0.030
 Why?
Gastroepiploic Artery
1
2015
4
0.030
 Why?
Cytoplasm
1
2017
257
0.030
 Why?
Mammary Arteries
1
2015
9
0.030
 Why?
Home Care Services
1
2019
280
0.030
 Why?
Inflammation
1
2007
2870
0.030
 Why?
Writing
1
2017
102
0.030
 Why?
Academic Medical Centers
1
2018
545
0.030
 Why?
Radial Artery
1
2015
72
0.030
 Why?
Green Fluorescent Proteins
1
2017
407
0.030
 Why?
Task Performance and Analysis
1
2016
198
0.030
 Why?
Fluorescent Dyes
1
2017
333
0.030
 Why?
Adaptor Proteins, Signal Transducing
1
2017
426
0.030
 Why?
Lymphocyte Activation
1
2017
1124
0.020
 Why?
Focus Groups
1
2016
566
0.020
 Why?
Antioxidants
1
2017
546
0.020
 Why?
Oxidation-Reduction
1
2017
1078
0.020
 Why?
Tumor Microenvironment
1
2017
729
0.020
 Why?
Solid Phase Microextraction
1
2012
7
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2012
127
0.020
 Why?
Breath Tests
1
2012
77
0.020
 Why?
Young Adult
3
2014
14122
0.020
 Why?
Gastroscopy
1
2012
18
0.020
 Why?
Silicones
1
2012
31
0.020
 Why?
Foreign-Body Migration
1
2012
33
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
174
0.020
 Why?
Biomechanical Phenomena
1
2015
852
0.020
 Why?
Gene Expression Regulation, Enzymologic
1
2012
268
0.020
 Why?
Analgesics, Opioid
1
2020
1142
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
1
2012
254
0.020
 Why?
Fibroblasts
1
2017
1019
0.020
 Why?
Forced Expiratory Volume
1
2012
448
0.020
 Why?
Gene Expression Profiling
2
2010
1766
0.020
 Why?
Lymphatic Metastasis
1
2012
334
0.020
 Why?
Device Removal
1
2012
142
0.020
 Why?
Debridement
1
2011
85
0.020
 Why?
False Positive Reactions
1
2011
122
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
973
0.020
 Why?
Air
1
2010
45
0.020
 Why?
Artifacts
1
2011
142
0.020
 Why?
Blotting, Western
1
2012
1161
0.020
 Why?
Global Health
1
2013
401
0.020
 Why?
Indazoles
1
2010
82
0.020
 Why?
Chest Pain
1
2010
99
0.020
 Why?
Adolescent
3
2014
22409
0.020
 Why?
Mice, Knockout
1
2017
3109
0.020
 Why?
Molecular Targeted Therapy
1
2012
437
0.020
 Why?
Photochemotherapy
1
2009
39
0.020
 Why?
Diarrhea
1
2010
192
0.020
 Why?
NF-kappa B
1
2012
657
0.020
 Why?
Drug Administration Schedule
1
2010
779
0.020
 Why?
Dose-Response Relationship, Drug
1
2012
2019
0.020
 Why?
Phosphorylation
1
2012
1704
0.020
 Why?
Cisplatin
1
2009
339
0.020
 Why?
Administration, Oral
1
2010
851
0.020
 Why?
Gene Expression Regulation
1
2017
2591
0.020
 Why?
Esophagoscopy
1
2009
221
0.020
 Why?
Electrocardiography
1
2011
664
0.020
 Why?
Decompression, Surgical
1
2008
116
0.020
 Why?
Pilot Projects
1
2012
1886
0.020
 Why?
Suicide
1
2014
725
0.020
 Why?
Carbonic Anhydrase IX
1
2006
4
0.010
 Why?
In Situ Hybridization, Fluorescence
1
2007
323
0.010
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
20
0.010
 Why?
Osteopontin
1
2006
35
0.010
 Why?
Biomarkers
1
2017
4261
0.010
 Why?
Tegafur
1
2005
12
0.010
 Why?
Platinum Compounds
1
2005
11
0.010
 Why?
Uracil
1
2005
36
0.010
 Why?
Lymphatic Diseases
1
2005
21
0.010
 Why?
Tracheal Diseases
1
2005
15
0.010
 Why?
Population Surveillance
1
2009
484
0.010
 Why?
Biopsy
1
2009
1079
0.010
 Why?
Catheter Ablation
1
2009
354
0.010
 Why?
Mediastinal Neoplasms
1
2005
53
0.010
 Why?
Drainage
1
2006
184
0.010
 Why?
Age Factors
1
2012
3329
0.010
 Why?
Meta-Analysis as Topic
1
2005
170
0.010
 Why?
Clone Cells
1
2005
263
0.010
 Why?
Kidney Failure, Chronic
1
2011
597
0.010
 Why?
Respiratory Mucosa
1
2007
322
0.010
 Why?
Aminocaproates
1
2004
2
0.010
 Why?
Cell Line, Tumor
1
2012
3523
0.010
 Why?
Lymphoma, Non-Hodgkin
1
2005
124
0.010
 Why?
RNA, Messenger
1
2012
2815
0.010
 Why?
Decision Trees
1
2004
79
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
751
0.010
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2005
331
0.010
 Why?
Mediastinum
1
2002
23
0.010
 Why?
Sensitivity and Specificity
1
2007
1995
0.010
 Why?
Hypertension
1
2010
1262
0.010
 Why?
Lymph Node Excision
1
2002
173
0.010
 Why?
Clinical Trials as Topic
1
2005
1056
0.010
 Why?
Cells, Cultured
1
2007
4110
0.010
 Why?
Blood Glucose
1
2009
2326
0.010
 Why?
Animals
1
2017
37948
0.010
 Why?
Mitchell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (452) concept(s)
_
Co-Authors Expand Description
See all (76) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)